Investigational Therapy in Mantle Cell Lymphoma: KTE-X19 CAR T-Cell Therapy

August 24, 2020

Michael Wang, MD, reacts to recent data and the potential to treat patients with relapsed or refractory mantle cell lymphoma with KTE-X19, an investigational CAR T-cell therapy.